Rutgers University
Piscataway, New Jersey, 08854, United States
Location status: Recruiting
NCT Number: NCT06773897
The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a diagnosis of cancer is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Piscataway, New Jersey, 08854, United States
Location status: Recruiting
This is an online research study to learn more about how genes affect the risk of breast cancer. No office visit is required and in return, participants may receive information about their genetic ancestry for free. BRCA1 and BRCA2 explain only about 25% of the genetic cause of breast cancer. This study will increase our understanding of the genetic basis of breast cancer, which is a crucial step in drug development to improve current treatment options. The study investigators seek a diverse population because men can also get breast cancer and diversity among participants maximizes the usefulness of the data. Participants will use our online study portal to answer questions about their health and provide their DNA via a saliva sample using a pre-paid mailer. Participation takes approximately 20 minutes. Participants will be invited to share data from their electronic health records, but this is not required for study participation. The study investigators keep participants engaged with short monthly newsletters.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Saliva sample is sent via prepaid US Mail for DNA extraction
Health surveys are filled out online in the study portal.
Time frame: 2 years
Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with breast cancer and breast cancer subtype.
Contact information is provided by the study sponsor or research team.
Steve Buyske, Ph.D.
CONTACT
Tara Matise, Ph.D.
CONTACT
Rutgers, The State University of New Jersey
Other
The Rutgers University Genetics Coordinating Center Breast Cancer Study
Acronym: RUGCC-BC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06722469
Breast Cancer Prevention, Breast Cancer Risk
View Trial DetailsNCT07014553
Breast Cancer Risk, Breast Diseases
Istanbul, Büyükçekmece, Turkey (Türkiye)
View Trial DetailsNCT04265547
Breast Cancer Risk, Breast Diseases
New York, United States
View Trial DetailsNCT05848856
Arterial Occlusive Diseases, Arteriosclerosis
Palo Alto, California, United States
View Trial Details